CARDIOVASCULAR THERAPEUTICS (ELECTRONIC)

Publisher： John Wiley & Sons Inc

Founded in： 1983

Total resources： 18

E-ISSN： 1755-5922

ISSN： 1755-5914

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC)

Menu

Hemodynamic impact of pulmonary vasodilators on single ventricle physiology

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Issue Information

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Tetrahydrobiopterin (BH4): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage‐dependent K+ channels in aortic smooth muscle

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 36, Iss. 1, 2018-02 , pp. n/a-n/a

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Issue Information

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC) , Vol. 34, Iss. 5, 2016-10 , pp. 295-296

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 8 Next Display item(s) per page Total 76 item(s)